Details for New Drug Application (NDA): 021472
✉ Email this page to a colleague
The generic ingredient in MIDOL LIQUID GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 021472
Tradename: | MIDOL LIQUID GELS |
Applicant: | Bionpharma |
Ingredient: | ibuprofen |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021472
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Oct 18, 2002 | TE: | RLD: | Yes |
Expired US Patents for NDA 021472
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bionpharma | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription